Zhang Songjie, Zhou Min, Ye Zhaoyang, Zhou Yan, Tan Wen-Song
State Key Laboratory of Bioreactor Engineering, School of Bioengineering, East China University of Science and Technology, Shanghai, P. R. China.
Biotechnol J. 2017 Aug;12(8). doi: 10.1002/biot.201700008. Epub 2017 Jul 5.
Slow vascularization often impedes the viability and function of engineered bone replacements. Prevascularization is a promising way to solve this problem. In this study, a new process was developed by integrating microcarrier culture and coculture to fabricate pre-vascularized bone microtissues with mesenchymal stem cells (MSCs) and human umbilical vein endothelial cells (HUVECs). Initially, coculture medium and cell ratio between MSCs and HUVECs were optimized in tissue culture plates concerning cell proliferation, osteogenesis and angiogenesis. Subsequently, cells were seeded onto CultiSpher S microcarriers in spinner flasks and subjected to a two-stage (proliferative-osteogenic) culture process for four weeks. Both cells proliferated and functioned well in chosen medium and a 1 : 1 ratio between MSCs and HUVECs was chosen for better angiogenesis. After four weeks of culture in spinner flasks, the microtissues were formed with high cellularity, evenly distributed cells and tube formation ability. While coculture with HUVECs exerted an inhibitory effect on osteogenic differentiation of MSCs, with downregulated alkaline phosphatase activity, mineralization and gene expression of COLI, RUNX2 and OCN, this could be attenuated by employing a delayed seeding strategy of HUVECs against MSCs during the microtissue fabrication process.
Collectively, this work established an effective method to fabricate pre-vascularized bone microtissues, which would lay a solid foundation for subsequent development of vascularized tissue grafts for bone regeneration.
血管化缓慢常常阻碍工程化骨替代物的存活和功能。预血管化是解决这一问题的一种有前景的方法。在本研究中,通过整合微载体培养和共培养开发了一种新方法,以用间充质干细胞(MSCs)和人脐静脉内皮细胞(HUVECs)制造预血管化骨微组织。首先,在组织培养板中针对细胞增殖、成骨和血管生成优化了共培养基以及MSCs和HUVECs之间的细胞比例。随后,将细胞接种到转瓶中的CultiSpher S微载体上,并进行为期四周的两阶段(增殖 - 成骨)培养过程。在选定的培养基中,两种细胞均增殖良好且功能正常,并且选择MSCs和HUVECs之间1:1的比例以实现更好的血管生成。在转瓶中培养四周后,形成了具有高细胞密度、细胞分布均匀且具有管形成能力的微组织。虽然与HUVECs共培养对MSCs的成骨分化产生抑制作用,碱性磷酸酶活性、矿化以及COLI、RUNX2和OCN的基因表达下调,但在微组织制造过程中采用HUVECs相对于MSCs的延迟接种策略可减弱这种抑制作用。
总体而言,这项工作建立了一种制造预血管化骨微组织的有效方法,这将为随后开发用于骨再生的血管化组织移植物奠定坚实基础。